Vasoplegia: A Review.

catecholamines septic shock vasodilatory shock vasoplegia vasopressors

Journal

Methodist DeBakey cardiovascular journal
ISSN: 1947-6108
Titre abrégé: Methodist Debakey Cardiovasc J
Pays: United States
ID NLM: 101508600

Informations de publication

Date de publication:
2023
Historique:
received: 17 04 2023
accepted: 03 05 2023
medline: 8 8 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: epublish

Résumé

Vasoplegia is a condition characterized by persistent low systemic vascular resistance despite a normal or high cardiac index, resulting in profound and uncontrolled vasodilation. Vasoplegia may occur due to various conditions, including cardiac failure, sepsis, and post-cardiac surgery. In the cardiac cohort, multiple risk factors for vasoplegia have been identified. Several factors contribute to the pathophysiology of this condition, and various mechanisms have been proposed, including nitric oxide, adenosine, prostanoids, endothelins, the renin-angiotensin-aldosterone system, and hydrogen sulfide. Early identification and prompt management of vasoplegia is crucial to prevent development of shock. This review expands upon the different vasopressors used in management of vasoplegia, including catecholamines such as norepinephrine, dopamine, epinephrine, phenylephrine, and other agents including vasopressin, methylene blue, angiotensin II, hydroxocobalamin, vitamin C, thiamine, and corticosteroids (ie, hydrocortisone). It also emphasizes the importance of conducting further research and making advancements in treatment regimens for vasoplegia.

Identifiants

pubmed: 37547893
doi: 10.14797/mdcvj.1245
pmc: PMC10402787
doi:

Substances chimiques

Epinephrine YKH834O4BH
Norepinephrine X4W3ENH1CV
Phenylephrine 1WS297W6MV

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-47

Informations de copyright

Copyright: © 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Références

J Cardiothorac Vasc Anesth. 2018 Apr;32(2):1013-1022
pubmed: 29223724
Eurasian J Med. 2022 Feb;54(1):92-99
pubmed: 35307639
Circulation. 2002 Jul 30;106(5):569-74
pubmed: 12147538
Biochem Biophys Res Commun. 1988 Oct 31;156(2):1007-14
pubmed: 3056398
JAMA. 2018 May 8;319(18):1889-1900
pubmed: 29801010
J Anesth. 2020 Apr;34(2):243-249
pubmed: 31900585
Anesth Analg. 1999 Nov;89(5):1143-55
pubmed: 10553825
Nature. 1987 Jun 11-17;327(6122):524-6
pubmed: 3495737
Eur J Cardiothorac Surg. 2004 Mar;25(3):327-32
pubmed: 15019656
Circulation. 2008 Apr 15;117(15):1991-6
pubmed: 18391107
Curr Opin Crit Care. 2007 Aug;13(4):383-91
pubmed: 17599007
Recent Pat Cardiovasc Drug Discov. 2006 Jan;1(1):95-108
pubmed: 17200683
Cureus. 2022 Aug 22;14(8):e28267
pubmed: 36039127
Semin Thorac Cardiovasc Surg. 2010 Summer;22(2):140-4
pubmed: 21092891
Circulation. 2009 Oct 27;120(17):1664-71
pubmed: 19822810
J Card Surg. 2021 Oct;36(10):3749-3760
pubmed: 34251716
J Cardiothorac Vasc Anesth. 2020 Oct;34(10):2766-2775
pubmed: 31917073
J Card Surg. 2021 Aug;36(8):2729-2734
pubmed: 34018257
Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):838-844
pubmed: 30649312
Ann Thorac Surg. 2004 Feb;77(2):496-9
pubmed: 14759425
J Physiol. 1984 Dec;357:67-77
pubmed: 6512706
Pharmacol Res. 2004 Jun;49(6):509-14
pubmed: 15026028
Chest. 2017 Jun;151(6):1229-1238
pubmed: 27940189
Crit Care. 2018 Feb 27;22(1):52
pubmed: 29486781
A A Pract. 2018 Aug 15;11(4):96-99
pubmed: 29634537
Crit Care. 2018 Jul 6;22(1):174
pubmed: 29980217
Circulation. 2006 Apr 4;113(13):1708-14
pubmed: 16585403
JAMA. 2021 Feb 23;325(8):742-750
pubmed: 33620405
Ann Thorac Surg. 2005 May;79(5):1615-9
pubmed: 15854942
Crit Care Med. 2006 Mar;34(3):640-5
pubmed: 16505647
Pediatrics. 1984 Oct;74(4):548-53
pubmed: 6435087
Front Biosci (Landmark Ed). 2009 Jan 01;14(5):1979-89
pubmed: 19273179
N Engl J Med. 2017 Aug 3;377(5):419-430
pubmed: 28528561
N Engl J Med. 2001 Aug 23;345(8):588-95
pubmed: 11529214
Nature. 1988 Mar 31;332(6163):411-5
pubmed: 2451132
J Immunol. 1990 May 1;144(9):3506-12
pubmed: 2109778
Eur J Pharmacol. 1989 Dec 12;174(1):119-22
pubmed: 2612574
J Cardiothorac Vasc Anesth. 2020 Feb;34(2):409-416
pubmed: 31526557
J Cardiovasc Surg (Torino). 1998 Oct;39(5):619-23
pubmed: 9833722
Georgian Med News. 2015 Feb;(239):56-62
pubmed: 25802451
Nutrients. 2018 Nov 14;10(11):
pubmed: 30441816
Pharmacol Rev. 1991 Jun;43(2):109-42
pubmed: 1852778
J Int Med Res. 2018 Apr;46(4):1303-1310
pubmed: 29332515
Am J Med Sci. 2015 Jan;349(1):80-8
pubmed: 25247756
Ann Thorac Surg. 2017 Jul;104(1):36-41
pubmed: 28551045
Biochim Biophys Acta. 1999 May 5;1411(2-3):334-50
pubmed: 10320667
Circulation. 2000 Nov 7;102(19):2434-40
pubmed: 11067800
J Am Heart Assoc. 2018 May 17;7(11):
pubmed: 29773577

Auteurs

Iqbal Ratnani (I)

Methodist DeBakey Heart & Vascular Center, Houston Methodist, Houston, Texas, US.

Rohan Kumar Ochani (RK)

SUNY Upstate Medical University, Syracuse, New York, US.

Asim Shaikh (A)

Aga Khan University, Karachi, Pakistan.

Hafsa Nazir Jatoi (HN)

Dow University of Health Sciences, Karachi, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH